Dergiler / Medicine Science / 2021 / Cilt: 10 - Sayı: 3

Assessment of fibrinogen levels in obstructive sleep apnea patients

Sayfa
770–774
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We suggest that elevated fibrinogen levels may be an essential factor in the pathogenesis of vascular disease in patients with OSAS.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Fibrinogen increases in the acute inflammatory response since it is an acute-phase reactant.
📊
Temel Bulgular & Veri:The study included 125 newly diagnosed patients with moderate to severe OSAS (defined as apnea-hypopnea index [AHI] ≥ 15) and 82 non-apneic control subjects (AHI<5).
💡
Sonuç & Katkı:We suggest that elevated fibrinogen levels may be an essential factor in the pathogenesis of vascular disease in patients with OSAS.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Fibrinogen increases in the acute inflammatory response since it is an acute-phase reactant. Fibrinogen was defined as an independent risk factor for cardiovascular diseases. We aimed to assess the alterations in plasma fibrinogen levels in patients with obstructive sleep apnea syndrome (OSAS) by comparing them with the control cases and determine their relationship with polysomnography (PSG) parameters. The study included 125 newly diagnosed patients with moderate to severe OSAS (defined as apnea-hypopnea index [AHI] ≥ 15) and 82 non-apneic control subjects (AHI<5). A full-night polysomnography was performed in all patients. After the sleep study, blood samples were drawn between 8:00 and 9:00 in the morning to measure fibrinogen levels. In OSAS patients, plasma fibrinogen levels were significantly higher than that of the control cases (4.4±0.12 g/L vs. 3.5±0.16 g/L; p:0.025). Positive correlations were reported between plasma fibrinogen levels and Epworth Sleepiness Scale (ESS) scores (r=0.299, p=0.006), age (r=0.327, p=0.003), body mass index (BMI) (r=0.391, p<0.001), average oxygen desaturation (r=0.258, p=0.019), oxygen desaturation index (r=0.279, p=0.009), time at <90% oxygen saturation (r=0.251, p=0.026), and arousal index (r=0.219, p=0.045). There was a negative correlation between plasma fibrinogen levels and the average oxygen saturation during sleep (r=-0.255, p=0.029). Increased ESS and BMI were related to elevated plasma fibrinogen levels, independent of AHI, in multiple regression analysis. Plasma fibrinogen levels are related with BMI and ESS that supports the link between hypoxia and inflammation. We suggest that elevated fibrinogen levels may be an essential factor in the pathogenesis of vascular disease in patients with OSAS.

🔖

Bu Makaleye Atıf Yap

ÇELİKHİSAR, H., DASDEMİR, G. İ. (2021). Assessment of fibrinogen levels in obstructive sleep apnea patients. Medicine Science, Cilt: 10 - Sayı: 3, 770–774. https://ajindex.com/articles/391425

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Borgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J. 2006;27:121-7. Lowe GD. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: not yet. J Thromb Haemost. 2005;3:635‐7. Naji DH, Tan C, Han F, et al. Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease. Mol Genet Genomics. 2018;293:119‐28. Zhang L, Xu C, Liu J, et al. Baseline plasma fibrinogen is associated withhemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study. Cardiovasc Diabetol. 2019;18:52. Lowe G, Woodward M, Hillis G, et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes. 2014;63:1115‐23. Meade TW, North WR, Chakrabarti R, et al. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980; 1:1050–4.
  2. Izci B, Ardic S, Firat H, et al. Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath. 2008;12:161-8. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd Ed. IL: American Academy of Sleep Medicine, 2014.
  3. Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: Types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69:841‐58. Anker SD, von Haehling S, Germany R. Sleep-disordered breathing and cardiovascular disease. Indian Heart J. 2016;68 Suppl 1: S69‐S76. Liu W, Yue H, Zhang J, et al. Effects of plasma ghrelin, obestatin, and ghrelin/obestatin ratio on blood pressure circadian rhythms in patients with obstructive sleep apnea syndrome. Chin Med J (Engl). 2014;127:850‐5. Baguet JP, Hammer L, Levy P, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apneic patients. J Hypertens. 2005;23:521–7.
  4. Li K, Chen Z, Qin Y, et al. MiR-664a-3p expression in patients with obstructive sleep apnea: A potential marker of atherosclerosis. Medicine (Baltimore). 2018;97:e9813. McArdle N, Riha RL, Vennelle M, et al. Sleep-disordered breathing as a risk factor for cerebrovascular disease: a case-control study in patients with transi